Technological Innovation Brings Enterprises to the International Stage
Release time:
2020-07-31
Editor's Note: As a senior enterprise in the extract industry for 17 years, Tianjin Jianfeng Natural Products Research and Development Company has devoted more time, energy and funds to R & D and innovation while doing a good job in business management. It has always been an important direction for them to achieve self breakthrough by turning waste into treasure and technological innovation. Therefore, it has achieved the improvement of market popularity at home and abroad and the rapid growth of sales volume, and has become a key science and technology enterprise in Tianjin Binhai New Area. 7# June 9 , "Bohai Morning Post" "TEDA Technology Little Giant Tour" column published an exclusive interview, telling the growth experience and a series of achievements of Tianjin Jianfeng Natural Products Company. This article will be reproduced in this newspaper for readers.
"Little Grape Seed" Grows into a Little Giant of Science and Technology Solves the Problem of Pesticide Residues in Plant Extracts
Technological Innovation Brings Enterprises to the International Stage
Based on Independent Innovation and Development, Starting from the Initial Grape Seed Extraction Process, it has gradually grown into China's largest professional fruit extract manufacturer with dozens of plant extract products that meet international stringent standards and an annual productivity of ,000 tons. Tianjin Jianfeng Natural Products Research and Development Co., Ltd. (hereinafter referred to as "Tianjin Jianfeng"), a development zone enterprise, has gone through ten years of rapid development. As a supplier of raw materials in health food, beverages, cosmetics, baked goods and many other fields, the concept of "truth and safety" advocated by Tianjin Jianfeng has run through all aspects of R & D and production. Its products are not only well-known in China, but also exported to Europe and the United States. Become a new business card of TEDA.
Technological innovation and international standards
"In people's lives, the beverages they drink, the health foods they eat, and the cosmetics they use all contain plant extracts. For example, grape seed extract is rich in proanthocyanidins, which are natural antioxidants. Therefore, the development of safe and high-quality extract products while reducing waste is the direction of our Tianjin Peak." Liu Dan, general manager of Tianjin Jianfeng, told reporters that after continuous technological innovation, the company has started from grape seed extraction and developed dozens of plant extract products such as apple polyphenols, ginsenosides, anthocyanins, resveratrol, soybean isoflavones, etc. In 2015 , the "JF-NATURAL " brand pure natural pesticide-free dietary supplement developed by the company was recognized as Tianjin's "killer product".
Why can it take the lead in the competition with domestic similar enterprises? Tianjin Jianfeng relies on continuous technological innovation and integration with international standards. "Our products are first and foremost international-oriented, and to be exported we have to meet international standards, so what is the difference between international standards and domestic standards? Simply put, most of the types of pesticide residues in imported products from Europe and the United States are times more than the national standard, which requires us to keep up with the international pace in terms of production processes and quality control." Liu Dan introduced.
In order to create its own brand internationally, it must also be outstanding. Removal of pesticide residues in extracts has always been a technical problem in the plant extraction industry. After years of efforts, Tianjin Jianfeng has invented a method that can not only remove pesticide residues in plant extracts but also retain their active ingredients, which meets the standards for pesticide residues in Europe and the United States, and has applied for a national invention patent. The technology has been successfully applied to the production of apple extract and ginseng extract, and the products are exported to the United States, Europe, Japan and other countries and regions.
Integrates Upstream and Downstream Industrial Resources
In 2015 , Tianjin Peak realized an output value of over 100 million yuan, double that of 5 years ago. Behind the figures are the changes in the two major international and domestic markets. "5 years ago, the international and domestic sales situation was 64, but now it is 46, indicating that the domestic market still has great potential."
While paying attention to expanding cooperation with dozens of domestic industry leaders, Tianjin Jianfeng integrates upstream and downstream industrial resources based on Binhai New Area and continuously expands the development space of enterprises. "in terms of geographical advantages, Binhai New area is rich in grapes, which is not far from the traditional producing areas such as apples and ginseng. At the same time, many of our customer enterprises are also located in Beijing and Tianjin, and there is Tianjin Port, which is convenient for import and export trade. it greatly facilitates the external relations of enterprises." Liu Dan said that the food processing and biomedical industries in Binhai New area are developing very fast, and the agglomeration effect of large enterprises is very conducive to the market expansion and large-scale operation of Tianjin Peak.
In Tianjin Peak, located in Huanghai 3rd Street, Development Zone, Liu Dan pointed to a large open area and said: "Next year, we will use this 30 mu of land to start the second phase of construction, focusing on the reuse of waste after plant extraction. For example, after the production of extracts in the past, grape seeds, grape skins, grapevines and other raw materials have been discarded, but now after years of technological accumulation, the technological level can fully meet the reuse of these wastes and promote the development of related industries. Not only grape series products, all our products must work hard in the direction of turning waste into treasure, and with the help of Binhai New Area, we can better revitalize the upstream and downstream industrial resources. We are confident that we will use another five years to achieve the goal of doubling the output value."
"real money and silver" helps enterprises to engage in research and development
Since entering the development zone in 2004 , Tianjin Jianfeng has gone through 12 years in TEDA. When it comes to the support of the development zone government to enterprises, Liu Dan summarizes it as "real money and silver"; 2005 5 , tianjin Jianfeng has established the first post-doctoral mobile workstation in the plant extraction industry, which has received strong support from the development zone government. Up to now, it has trained 4 post-doctoral talents. In 2008 , with the support of the development zone's policy to promote the development of high-tech industries, Jianfeng Company established an internal research and development organization and won a reward of 100 yuan from the development zone. 2010 , in cooperation with Tianjin Pharmaceutical Research Institute, Tianjin University of Science and Technology, Nankai University School of Pharmacy and Shenyang Pharmaceutical University, the "Tianjin Plant Waste Reuse Technology Engineering Center" was established. In 2015 , Jianfeng Company passed the accreditation of Tianjin Enterprise Technology Center and won the award of Yuan from the Development Zone. 2016 , tianjin Jianfeng Company was listed in the "Development Zone Science and Technology Innovation 20 Enterprises".
Liu Dan recalled, "Over the years, through policy fulfillment, tax incentives, patent and trademark applications, national and municipal science and technology plan projects, fixed asset upgrades and many other fields, we have received millions of yuan in the development zone. Financial support, which greatly reduces the cost of enterprise process technology research and development. Therefore, in the future, we will be based on TEDA, do a good job in the construction of the second phase of the plant, and contribute to TEDA's economic construction." (Bohai Morning Post reporter Xu Xin)
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page